组蛋白去乙酰化酶抑制剂SAHA与紫杉醇联合治疗对小鼠全层创面愈合的影响
本研究在小鼠全层创面模型中探讨SAHA联合紫杉醇对创面愈合的影响。另16只荷MDA-MB-231移植瘤裸鼠比较肿瘤体积。结果显示联合治疗缩短紫杉醇延长的愈合时间,且抗肿瘤效果优于紫杉醇单药。
要点
- 紫杉醇单药组平均创面愈合时间延长至20±1.9天,联合SAHA组为17.0±1.8天。
- SAHA联合紫杉醇组平均肿瘤体积43.9±34.1 mm,小于紫杉醇单药组105.8±73.8 mm。
- SAHA联合紫杉醇可在不减弱抗肿瘤效果的前提下改善创面愈合。
核心结论
- SAHA联合紫杉醇可改善三阴性乳腺癌的抗肿瘤疗效,同时减轻紫杉醇对创面愈合的不良影响。
研究设计与样本
- 16只荷MDA-MB-231移植瘤裸鼠接受相同处理,比较肿瘤体积。
主要发现
- 紫杉醇组平均创面愈合时间为20±1.9天,联合SAHA组为17.0±1.8天。
- 移植瘤模型中,SAHA联合紫杉醇组平均肿瘤体积43.9±34.1 mm,紫杉醇单药组为105.8±73.8 mm。
临床怎么用
- 提示在紫杉醇新辅助化疗期间加用SAHA可能减轻创面愈合延迟,并可能改善化疗后乳房再造的结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Neoadjuvant chemotherapy prior to lumpectomy or mastectomy for breast cancer challenges wound healing. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, has been shown to work synergistically with paclitaxel in vitro and in preclinical studies. In addition, our laboratory has demonstrated that SAHA treatment decreases paclitaxel-associated stem cell toxicity, modulates inflammatory response, and promotes wound healing in injured fibroblast cells. Our goal was to determine if combined SAHA and paclitaxel treatment would improve wound healing in an in vivo full-thickness murine model, without altering antitumor effect. METHODS: Thirty-two nude athymic mice received intraperitoneal injections of paclitaxel (20 mg/kg), SAHA (25 mg/kg), paclitaxel + SAHA (20 mg/kg + 25 mg/kg), or no treatment for 2 weeks prior to surgery. Under general anesthesia, 8-mm full-thickness dorsal wounds were created in all animals, and a silicone splint was attached to minimize wound contraction. The wounds were measured twice a week with a surgical caliper until healing was complete. To evaluate the in vivo effect of drug treatment, 16 athymic nude mice with MDA-MB-231 xenografts received the treatments described previously, following which tumor volumes were compared between groups. RESULTS: Average wound healing time was prolonged in mice treated with paclitaxel (20 ± 1.9 days), and combination SAHA + paclitaxel therapy improved average wound healing time (17.0 ± 1.8 days). In the xenograft model, the antitumor effect of SAHA and paclitaxel (average tumor volume 43.9 ± 34.1 mm) was greater than paclitaxel alone (105.8 ± 73.8 mm). CONCLUSIONS: The addition of SAHA to taxane chemotherapy improves the therapeutic effect on triple-negative breast cancer while decreasing the detrimental effect of paclitaxel on wound healing. This may have substantial implications on improving outcomes in breast reconstruction following chemotherapy.
引用
- Marcotte JH, Rattigan DA, Irons RF, et al. The Effect of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Paclitaxel Treatment on Full-Thickness Wound Healing in Mice. Ann Plast Surg. 2018. PMID: 29905606. doi:10.1097/SAP.0000000000001519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。